Sapiens International Redeems Series B Debentures

Sapiens International Corp N V 6-K Filing Summary
FieldDetail
CompanySapiens International Corp N V
Form Type6-K
Filed DateOct 20, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$20 million, $66.2 million
Sentimentneutral

Sentiment: neutral

Topics: debt-redemption, financing

TL;DR

Sapiens is paying off its Series B Debentures early, effective Oct 19, 2025.

AI Summary

On October 19, 2025, Sapiens International Corporation N.V. announced the full early redemption of its outstanding Series B Debentures. These unsecured, non-convertible debentures are listed and traded exclusively on the Tel Aviv Stock Exchange (TASE). The company's Board of Directors approved this redemption.

Why It Matters

This action indicates a potential shift in the company's capital structure or debt management strategy, which could impact its financial leverage and investor perception.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a debt redemption, not indicating any immediate financial distress or significant operational change.

Key Players & Entities

  • Sapiens International Corporation N.V. (company) — The company making the announcement.
  • Series B Debentures (debt_instrument) — The financial instrument being redeemed.
  • Tel Aviv Stock Exchange (TASE) (company) — The exchange where the debentures are traded.
  • October 19, 2025 (date) — The date the Board of Directors approved the redemption.

FAQ

What is the total principal amount of the Series B Debentures being redeemed?

The filing does not specify the total principal amount of the Series B Debentures outstanding or being redeemed.

What is the redemption date for the Series B Debentures?

The Board of Directors approved the full early redemption on October 19, 2025.

Are the Series B Debentures convertible?

No, the Series B Debentures are described as non-convertible.

Where are the Series B Debentures listed?

The Series B Debentures are listed and traded solely on the Tel Aviv Stock Exchange (TASE).

What is the financial nature of the Series B Debentures?

The Series B Debentures are described as unsecured.

Filing Stats: 689 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2025-10-20 06:04:34

Key Financial Figures

  • $20 million — o be NIS 66.6 million (approximately US $20 million). Upon completion of the Redemption, t
  • $66.2 million — ly NIS 234.14 million (approximately US $66.2 million at the time). The Series B Debentures b

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SAPIENS INTERNATIONAL CORPORATION N.V. Date: October 20, 2025 By: /s/ Roni Giladi Name: Roni Giladi Title: Chief Financial Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.